Senti Biosciences is trading 10.85% up at $0.19 on October 27; no clear company-specific announcement explaining the gain surfaced.

  • The XBI sector rose 2.18% during the regular session, offering supportive sector context; available information does not establish that merger news caused the gain.
  • The latest reported transaction, completed October 21 and disclosed October 26, divested Senti’s former operating businesses; potential shareholder payments depend on future milestones.